High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia

摘要

BackgroundAcute myeloid leukemia (AML) is a highly heterogeneous malignancy with various outcomes, and therefore needs better risk stratification tools to help select optimal therapeutic options.